VERU INC. Deferred Income Tax Assets, Net
VERU INC. (VERU) had Deferred Income Tax Assets, Net of $12.34 million as of 2024-09-30, per its 10-K filed 2024-12-16.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2024-12-16
- 2024-09-30: Deferred Income Tax Assets, Net $12.34M.
- 2024-06-30: Deferred Income Tax Assets, Net $12.48M.
- 2024-03-31: Deferred Income Tax Assets, Net $12.64M.
- 2023-12-31: Deferred Income Tax Assets, Net $12.79M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2024-09-30 | $12.34M 10-K · filed 2024-12-16 |
| 2024-06-30 | $12.48M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $12.64M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $12.79M 10-Q · filed 2024-04-01 |
| 2023-09-30 | $12.71M 10-K · filed 2024-12-16 |
| 2023-06-30 | $13.10M 10-Q/A · filed 2023-11-15 |
| 2023-03-31 | $13.07M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $13.05M 10-Q · filed 2023-02-09 |
| 2022-09-30 | $12.97M 10-K/A · filed 2024-04-01 |
| 2022-06-30 | $13.01M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $13.02M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $12.93M 10-Q · filed 2022-02-09 |
| 2021-09-30 | $13.02M 10-K · filed 2022-12-05 |
| 2021-06-30 | $12.38M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $9.44M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $9.43M 10-Q · filed 2021-02-10 |
| 2020-09-30 | $9.47M 10-K · filed 2021-12-02 |
| 2020-06-30 | $8.63M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $8.63M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $8.59M 10-Q · filed 2020-02-12 |
| 2019-09-30 | $8.43M 10-K · filed 2020-12-10 |
| 2018-09-30 | $8.54M 10-K · filed 2019-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |